Cairns N - Search Results

1

Endogenous opioids in frontal cortex of patients with Down syndrome.

Risser D, You ZB, Cairns N, Herrera-Marschitz M, Seidl R, Schneider C, Terenius L, Lubec G. Risser D, et al. Among authors: cairns n. Neurosci Lett. 1996 Jan 19;203(2):111-4. doi: 10.1016/0304-3940(95)12275-3. Neurosci Lett. 1996. PMID: 8834106

2

Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome.

Baran H, Cairns N, Lubec B, Lubec G. Baran H, et al. Among authors: cairns n. Life Sci. 1996;58(21):1891-9. doi: 10.1016/0024-3205(96)00173-7. Life Sci. 1996. PMID: 8637415

3

Polyamines in frontal cortex of patients with Down syndrome and Alzheimer disease.

Seidl R, Beninati S, Cairns N, Singewald N, Risser D, Bavan H, Nemethova M, Lubec G. Seidl R, et al. Among authors: cairns n. Neurosci Lett. 1996 Mar 15;206(2-3):193-5. doi: 10.1016/s0304-3940(96)12451-4. Neurosci Lett. 1996. PMID: 8710184

4

Relationships between beta-amyloid (A beta) deposits and blood vessels in patients with sporadic and familial Alzheimer's disease.

Armstrong RA, Cairns NJ, Patel R, Lantos PL, Rossor MN. Armstrong RA, et al. Among authors: cairns nj. Neurosci Lett. 1996 Apr 5;207(3):171-4. doi: 10.1016/0304-3940(96)12525-8. Neurosci Lett. 1996. PMID: 8728477

5

Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease.

Hayn M, Kremser K, Singewald N, Cairns N, Nemethova M, Lubec B, Lubec G. Hayn M, et al. Among authors: cairns n. Life Sci. 1996;59(7):537-44. doi: 10.1016/0024-3205(96)00334-7. Life Sci. 1996. PMID: 8761342

6

Decreased cyclin dependent kinase in brain of patients with Down syndrome.

Bernert G, Nemethova M, Herrera-Marschitz M, Cairns N, Lubec G. Bernert G, et al. Among authors: cairns n. Neurosci Lett. 1996 Sep 20;216(1):68-70. doi: 10.1016/0304-3940(96)12988-8. Neurosci Lett. 1996. PMID: 8892394

7

Excitatory amino acids and monoamines in parahippocampal gyrus and frontal cortical pole of adults with Down syndrome.

Risser D, Lubec G, Cairns N, Herrera-Marschitz M. Risser D, et al. Among authors: cairns n. Life Sci. 1997;60(15):1231-7. doi: 10.1016/s0024-3205(97)00067-2. Life Sci. 1997. PMID: 9096240

8

Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease.

Schneider C, Risser D, Kirchner L, Kitzmüller E, Cairns N, Prast H, Singewald N, Lubec G. Schneider C, et al. Among authors: cairns n. Neurosci Lett. 1997 Feb 7;222(3):183-6. doi: 10.1016/s0304-3940(97)13379-1. Neurosci Lett. 1997. PMID: 9148245

9

Evidence against increased glycoxidation in patients with Alzheimer's disease.

Seidl R, Schuller E, Cairns N, Lubec G. Seidl R, et al. Among authors: cairns n. Neurosci Lett. 1997 Aug 22;232(1):49-52. doi: 10.1016/s0304-3940(97)00576-4. Neurosci Lett. 1997. PMID: 9292889

10

Evidence against increased oxidative DNA-damage in Down syndrome.

Seidl R, Greber S, Schuller E, Bernert G, Cairns N, Lubec G. Seidl R, et al. Among authors: cairns n. Neurosci Lett. 1997 Oct 17;235(3):137-40. doi: 10.1016/s0304-3940(97)00748-9. Neurosci Lett. 1997. PMID: 9406888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

777 results

Search Page

Filters